4//SEC Filing
ROBINS HARLAN S 4
Accession 0001062993-25-004810
CIK 0001478320other
Filed
Mar 5, 7:00 PM ET
Accepted
Mar 6, 7:18 PM ET
Size
7.9 KB
Accession
0001062993-25-004810
Insider Transaction Report
Form 4
ROBINS HARLAN S
Chief Scientific Officer
Transactions
- Award
Common Stock
2025-03-04+355,000→ 1,376,180 total - Sale
Common Stock
2025-03-05$6.99/sh−56,053$391,810→ 1,279,524 total - Sale
Common Stock
2025-03-05$6.98/sh−40,603$283,409→ 1,335,577 total
Footnotes (1)
- [F1]This transaction represents the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of RSUs. This sale is mandated by Issuer's election under the equity incentive plans to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.
Issuer
Adaptive Biotechnologies Corp
CIK 0001478320
Entity typeother
Related Parties
1- filerCIK 0001780851
Filing Metadata
- Form type
- 4
- Filed
- Mar 5, 7:00 PM ET
- Accepted
- Mar 6, 7:18 PM ET
- Size
- 7.9 KB